Population pharmacokinetics of teicoplanin in hospitalized elderly patients using cystatin C as an indicator of renal function

Journal of Infection and Chemotherapy - Tập 24 - Trang 284-291 - 2018
Hidefumi Kasai1,2, Yasuhiro Tsuji1, Yoichi hiraki3, Moeko Tsuruyama3, Hideto To1, Yoshihiro Yamamoto4
1Department of Medical Pharmaceutics, Faculty of Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama, Toyama, 930-0194, Japan
2Certara G.K., 4-2-12, Minato-ku, Tokyo, 105-0001, Japan
3Department of Pharmacy, National Hospital Organization Beppu Medical Center, 1473 Uchikamado, Beppu, Oita, 874-0011, Japan
4Department of Clinical Infectious Diseases, Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama, 2630 Sugitani, Toyama, Toyama, 930-0194, Japan

Tài liệu tham khảo

Cosgrove, 2005, The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges, Infect Contr Hosp Epidemiol, 26, 166, 10.1086/502522

Shorr, 2006, Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy, Crit Care Med, 34, 700, 10.1097/01.CCM.0000201885.57697.21

Borghi, 1991, Factors affecting the normal and branched-chain acyl moieties of teicoplanin components produced by Actinoplanes teichomyceticus, J Gen Microbiol, 137, 587, 10.1099/00221287-137-3-587

Greenwood, 1988, Microbiological properties of teicoplanin, J Antimicrob Chemother, 21, 1, 10.1093/jac/21.suppl_A.1

Pallanza, 1983, Teichomycin: in-vitro and in-vivo evaluation in comparison with other antibiotics, J Antimicrob Chemother, 11, 419, 10.1093/jac/11.5.419

Rowland, 1990, Clinical pharmacokinetics of teicoplanin, Clin Pharmacokinet, 18, 184, 10.2165/00003088-199018030-00002

Wilson, 2000, Clinical pharmacokinetics of teicoplanin, Clin Pharmacokinet, 39, 167, 10.2165/00003088-200039030-00001

Matsumoto, 2010, Determination of teicoplanin trough concentration target and appropriate total dose during the first 3 days: a retrospective study in patients with MRSA infections, J Infect Chemother : Official Journal of the Japan Society of Chemotherapy, 16, 193, 10.1007/s10156-010-0038-8

Niwa, 2010, Significance of individual adjustment of initial loading dosage of teicoplanin based on population pharmacokinetics, Int J Antimicrob Agents, 35, 507, 10.1016/j.ijantimicag.2009.12.018

Hiraki, 2015, Optimal loading regimen and achievement of trough concentrations for teicoplanin using Japanese population parameters, Int J Antimicrob Agents, 45, 87, 10.1016/j.ijantimicag.2014.09.014

Brink, 2008, Gauteng Understanding Teicoplanin Serum levels study g. Recommendations to achieve rapid therapeutic teicoplanin plasma concentrations in adult hospitalised patients treated for sepsis, Int J Antimicrob Agents, 32, 455, 10.1016/j.ijantimicag.2008.05.012

Lamont, 2009, Development of teicoplanin dosage guidelines for patients treated within an outpatient parenteral antibiotic therapy (OPAT) programme, J Antimicrob Chemother, 64, 181, 10.1093/jac/dkp147

Mimoz, 2006, Steady-state trough serum and epithelial lining fluid concentrations of teicoplanin 12 mg/kg per day in patients with ventilator-associated pneumonia, Intensive Care Med, 32, 775, 10.1007/s00134-006-0136-3

Pea, 2004, Teicoplanin in patients with acute leukaemia and febrile neutropenia: a special population benefiting from higher dosages, Clin Pharmacokinet, 43, 405, 10.2165/00003088-200443060-00004

Seki, 2012, Loading regimen required to rapidly achieve therapeutic trough plasma concentration of teicoplanin and evaluation of clinical features, Clin Pharmacol, 4, 71

Tobin, 2010, Analyses of teicoplanin concentrations from 1994 to 2006 from a UK assay service, J Antimicrob Chemother, 65, 2155, 10.1093/jac/dkq266

Ueda, 2014, High-dose regimen to achieve novel target trough concentration in teicoplanin, J Infect Chemother, 20, 43, 10.1016/j.jiac.2013.08.006

Gordts, 2000, National guidelines for the judicious use of glycopeptides in Belgium, Clin Microbiol Infect, 6, 585, 10.1046/j.1469-0691.2000.00165.x

Gould, 2012, Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy, J Antimicrob Chemother, 67, 269, 10.1093/jac/dkr450

Greenberg, 1990, Treatment of bone, joint, and vascular-access-associated gram-positive bacterial infections with teicoplanin, Antimicrob Agents Chemother, 34, 2392, 10.1128/AAC.34.12.2392

Harding, 2000, Comparative pharmacokinetics of teicoplanin and vancomycin, J Chemother, 12, 15

Matthews, 2007, Teicoplanin levels in bone and joint infections: are standard doses subtherapeutic?, J Infect, 55, 408

Schmit, 1992, Efficacy of teicoplanin for enterococcal infections: 63 cases and review, Clin Infect Dis, 15, 302, 10.1093/clinids/15.2.302

Nakamura, 2015, Development of a teicoplanin loading regimen that rapidly achieves target serum concentrations in critically ill patients with severe infections, J Infect Chemother, 21, 449, 10.1016/j.jiac.2015.02.002

Frye, 1992, Teicoplanin nephrotoxicity: first case report, Pharmacotherapy, 12, 240

Wilson, 1998, Comparative safety of teicoplanin and vancomycin, Int J Antimicrob Agents, 10, 143, 10.1016/S0924-8579(98)00025-9

Cockcroft, 1976, Prediction of creatinine clearance from serum creatinine, Nephron, 16, 31, 10.1159/000180580

Imai, 2007, Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease, Clin Exp Nephrol, 11, 41, 10.1007/s10157-006-0453-4

Levey, 2006, Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate, Ann Intern Med, 145, 247, 10.7326/0003-4819-145-4-200608150-00004

Simonsen, 1985, The Blood-Serum Concentration of Cystatin-C (Gamma-Trace) as a Measure of the Glomerular-Filtration Rate, Scand J Clin Lab Invest, 45, 97, 10.3109/00365518509160980

Filler, 2005, Cystatin C as a marker of GFR – history, indications, and future research, Clin Biochem, 38, 1, 10.1016/j.clinbiochem.2004.09.025

Hoek, 2003, A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate, Nephrol Dial Transplant, 18, 2024, 10.1093/ndt/gfg349

Larsson, 2004, Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/L, Scand J Clin Lab Invest, 64, 25, 10.1080/00365510410003723

Grubb, 2005, A cystatin C-based formula without anthropometric variables estimates glomerular filtration rate better than creatinine clearance using the Cockcroft-Gault formula, Scand J Clin Lab Invest, 65, 153, 10.1080/00365510510013596

Sjostrom, 2005, Determination of the production rate and non-renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans, Scand J Clin Lab Invest, 65, 111, 10.1080/00365510510013523

Grubb, 2005, Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children, Clin Chem, 51, 1420, 10.1373/clinchem.2005.051557

Filler, 2003, Glomerular filtration rate as a putative 'surrogate end-point' for renal transplant clinical trials in children, Pediatr Transplant, 7, 18, 10.1034/j.1399-3046.2003.00015.x

Tanaka, 2004, A sol particle homogeneous immunoassay for measuring serum cystatin C., Clin Biochem, 37, 27, 10.1016/j.clinbiochem.2003.08.001

Dubois, 1989, Nutrition metabolism classic – a formula to estimate the approximate surface-area if height and weight be known, Nutrition, 5, 303

Ette, 1997, Stability and performance of a population pharmacokinetic model, J Clin Pharmacol, 37, 486, 10.1002/j.1552-4604.1997.tb04326.x

Bergstrand, 2011, Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models, AAPS J, 13, 143, 10.1208/s12248-011-9255-z

Honda, 2008, Population pharmacokinetics of landiolol hydrochloride in healthy subjects, Drug Metabol Pharmacokinet, 23, 447, 10.2133/dmpk.23.447

Lortholary, 1996, Population pharmacokinetic study of teicoplanin in severely neutropenic patients, Antimicrob Agents Chemother, 40, 1242, 10.1128/AAC.40.5.1242

Soy, 2006, Teicoplanin population pharmacokinetic analysis in hospitalized patients, Ther Drug Monit, 28, 737, 10.1097/01.ftd.0000249942.14145.ff

Ogawa, 2013, Population pharmacokinetic and pharmacodynamic analyses of teicoplanin in Japanese patients with systemic MRSA infection, Int J Clin Pharmacol Ther, 51, 357, 10.5414/CP201739

Ramos-Martin, 2014, Population pharmacokinetics of teicoplanin in children, Antimicrob Agents Chemother, 58, 6920, 10.1128/AAC.03685-14

Zhao, 2015, Population pharmacokinetics and dosing optimization of teicoplanin in children with malignant haematological disease, Br J Clin Pharmacol, 80, 1197, 10.1111/bcp.12710

Ramos-Martin, 2016, Population pharmacokinetics and pharmacodynamics of teicoplanin in neonates: making better use of C-reactive protein to deliver individualized therapy, J Antimicrob Chemother, 71, 3168, 10.1093/jac/dkw295

Dharnidharka, 2002, Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis, Am J Kidney Dis, 40, 221, 10.1053/ajkd.2002.34487

Schuck, 2004, Predicting the glomerular filtration rate from serum creatinine, serum cystatin C and the Cockcroft and Gault formula with regard to drug dosage adjustment, Int J Clin Pharmacol Ther, 42, 93, 10.5414/CPP42093

Kozono, 2016, Comparison of predictive accuracy of teicoplanin concentration using creatinine clearance and glomerular filtration rate estimated by serum creatinine or cystatin C, J Infect Chemother, 22, 314, 10.1016/j.jiac.2016.01.024

Hooker, 2007, Conditional weighted residuals (CWRES): a model diagnostic for the FOCE method, Pharm Res., 24, 2187, 10.1007/s11095-007-9361-x

Finney, 1999, Plasma cystatin C determinations in a healthy elderly population, Arch Gerontol Geriatr, 29, 75, 10.1016/S0167-4943(99)00025-4

Thông tin
Thông tin xuất bản

Journal of Infection and Chemotherapy

Tập 24

284-291

Thông tin tác giả